JPH0489051A - Superficial cancer and deep cancer therapeutic tool - Google Patents
Superficial cancer and deep cancer therapeutic toolInfo
- Publication number
- JPH0489051A JPH0489051A JP2204101A JP20410190A JPH0489051A JP H0489051 A JPH0489051 A JP H0489051A JP 2204101 A JP2204101 A JP 2204101A JP 20410190 A JP20410190 A JP 20410190A JP H0489051 A JPH0489051 A JP H0489051A
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- chemical
- heat
- deep
- superficial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 62
- 201000011510 cancer Diseases 0.000 title claims abstract description 57
- 239000012830 cancer therapeutic Substances 0.000 title 1
- 239000000126 substance Substances 0.000 claims abstract description 36
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 239000003575 carbonaceous material Substances 0.000 claims abstract description 9
- 239000000919 ceramic Substances 0.000 claims abstract description 4
- 239000010457 zeolite Substances 0.000 claims abstract description 3
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims abstract 2
- 229910052726 zirconium Inorganic materials 0.000 claims abstract 2
- 238000011282 treatment Methods 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 13
- 229910052742 iron Inorganic materials 0.000 claims description 9
- 239000000463 material Substances 0.000 abstract description 7
- 238000010438 heat treatment Methods 0.000 abstract description 6
- 230000006378 damage Effects 0.000 abstract description 4
- 229910021536 Zeolite Inorganic materials 0.000 abstract description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 abstract description 2
- 239000002131 composite material Substances 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000015 thermotherapy Methods 0.000 description 5
- 206010006187 Breast cancer Diseases 0.000 description 4
- 208000026310 Breast neoplasm Diseases 0.000 description 4
- 206010009944 Colon cancer Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- 208000000453 Skin Neoplasms Diseases 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- -1 atreamine Chemical compound 0.000 description 3
- 210000001072 colon Anatomy 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 201000000849 skin cancer Diseases 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 201000009030 Carcinoma Diseases 0.000 description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
- 206010020843 Hyperthermia Diseases 0.000 description 2
- PPQNQXQZIWHJRB-UHFFFAOYSA-N Methylcholanthrene Chemical compound C1=CC=C2C3=CC4=CC=C(C)C(CC5)=C4C5=C3C=CC2=C1 PPQNQXQZIWHJRB-UHFFFAOYSA-N 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 208000015634 Rectal Neoplasms Diseases 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 239000013043 chemical agent Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000036031 hyperthermia Effects 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 206010038038 rectal cancer Diseases 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 201000001275 rectum cancer Diseases 0.000 description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000009217 hyperthermia therapy Methods 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229940015367 pyrethrum Drugs 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 235000019795 sodium metasilicate Nutrition 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000000112 undernutrition Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Radiation-Therapy Devices (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は表在癌および深部癌治療具に関する。[Detailed description of the invention] [Industrial application field] The present invention relates to a device for treating superficial cancer and deep cancer.
さらに詳細には本発明は、鉄粉、塩類、水および炭素質
物質からなる発熱組成物を収納した化学力イロを熱源と
して用いた表在癌および深部癌治療具に関する。なお、
本発明でいう癌は悪性肉腫およびリンパ腫をも包含する
。More specifically, the present invention relates to a device for treating superficial cancer and deep cancer using a chemical iron as a heat source containing a heat generating composition consisting of iron powder, salts, water and carbonaceous material. In addition,
Cancer as used in the present invention also includes malignant sarcoma and lymphoma.
従来、癌の治療法としては、+1)外科的治療(患部お
よび所属リンパ節の切除)、(2)化学的治療(抗癌剤
の投与など)、(3)免疫療法(インターフェロン、イ
ンターロイキンなとの投与)、(4)放射線療法などが
あり、癌か発見されると切除可能な場合にはます外科的
治療が行われ、次いで抗癌剤の投与その他の治療が施さ
れるのか通例であった。Traditionally, cancer treatment methods include: +1) surgical treatment (removal of the affected area and regional lymph nodes), (2) chemical treatment (administration of anticancer drugs, etc.), and (3) immunotherapy (interferon, interleukin, etc.). (4) radiation therapy, etc. Once cancer is discovered, surgical treatment is performed if it is resectable, followed by administration of anticancer drugs and other treatments.
しかし、上記に示す治療法は全て少なからず患者の健全
な部位にも障害を与えるものであるし、しかも近年重要
視されている患者の快適性(クォリティ・オブ・ライフ
)を満足させるものではない。例えば、女性に多(みら
れる乳癌で、乳房を切除される女性の精神的苦痛は甚た
大きい。However, all of the above-mentioned treatments cause considerable damage to the patient's healthy body parts, and they do not satisfy the patient's comfort (quality of life), which has become important in recent years. . For example, breast cancer is common in women, and women who have their breasts removed suffer tremendous psychological pain.
一方、患者の健全な部位に比較的障害を与えず、患者の
快適性を満足させ生活の質を下げずに治療を行える癌治
療法として温熱療法がある。On the other hand, thermotherapy is a cancer treatment method that does not cause any damage to the patient's healthy parts, satisfies the patient's comfort, and can be treated without reducing the quality of life.
温熱療法は、■細胞の生存率は42°C以上の加温によ
り急激に低下するか、この傾向は正常細胞より癌細胞で
強い(なお、正常細胞への影響を考慮すると42〜45
°Cの範囲か温熱療法には好ましい)、■癌組織では正
常組織に比してその環境(低栄養、低酸素、低pH)お
よび血管構築の特殊性により加温されやすく、従って癌
が選択的に壊死に陥りやすい、などの性質を利用するも
のである。具体的には、(1)局所温熱療法(高周波療
法、腹膜還流法など) 、(2)全身温熱療法(動脈か
ら血液を取り出し、45℃に加温した後、静脈に戻す)
があり、一般にマイトマイシン、アトレアマインン、シ
スプラチンなとを投与する化学療法と併用されることが
多い。Hyperthermia therapy is as follows: ■Cell survival rate decreases rapidly with heating above 42°C, and this tendency is stronger in cancer cells than in normal cells (taking into account the effect on normal cells, 42-45
°C range or preferred for hyperthermia), ■ Cancerous tissues are more easily heated than normal tissues due to their environment (undernutrition, hypoxia, low pH) and special characteristics of blood vessel construction, and therefore cancer is selected. This method takes advantage of properties such as the fact that it is easily susceptible to necrosis. Specifically, (1) local thermotherapy (high frequency therapy, peritoneal perfusion method, etc.), (2) whole body thermotherapy (blood is removed from the artery, heated to 45°C, and then returned to the vein).
It is often used in combination with chemotherapy, which generally includes mitomycin, atreamine, and cisplatin.
しかしなから、これらの従来の温熱療法は、高周波発生
装置なと非常に高価な装置を必要としたり、体内で温水
を還流させるため患者に苦痛を与えたり、患者を固定し
麻酔をかける必要があったりして、必すしも広範囲に受
入れられる治療法ではなかった。近年、加温装置なとの
改良によりこの分野の開発は進んでいるものの、依然と
して高価な治療法であるとの認識か強いのか現状である
。However, these conventional hyperthermia treatments require very expensive equipment such as high-frequency generators, cause pain to the patient because hot water is circulated inside the body, and require the patient to be immobilized and anesthetized. However, it was not necessarily a widely accepted treatment. Although development in this field has progressed in recent years with improvements such as heating devices, there is still a strong perception that it is an expensive treatment method.
本発明は、上記従来技術の問題点に鑑み、正常組織に障
害を与えることなく癌組織のみを死滅させ、しかも手軽
で安価にかつ患者の生活の質を下げずに利用できる温熱
癌治療具を提供する目的でなされたものである。In view of the problems of the prior art described above, the present invention provides a thermal cancer treatment device that kills only cancerous tissue without damaging normal tissue, and that can be used easily and inexpensively without reducing the quality of life of the patient. This was done for the purpose of providing.
癌組織を42〜45°Cに保持するためには、定に加温
する熱源を必要とするが、本発明者等は、鉄粉、塩類、
水、炭素質物質からなる発熱組成物を収納した化学力イ
ロを熱源として用いることを試み、鋭意検討した結果、
前記化学力イロか酸素と接触するたけで容易に発熱か始
まり、患部を2時間以上持続して42〜45℃に保持す
るのに十分な発熱量を有するとともに、簡便かつ安価に
使用でき、従来の温熱療法に比較してより患者の快適性
を満足させるものであることを見出し、本発明を完成す
るに到った。In order to maintain cancer tissue at 42-45°C, a heat source that constantly heats it is required, but the present inventors have developed a method using iron powder, salts,
As a result of intensive study, we attempted to use a chemical power source containing a heat-generating composition consisting of water and carbonaceous materials as a heat source.
Fever starts easily upon contact with oxygen, has enough calorific value to maintain the affected area at 42-45°C for more than 2 hours, is simple and inexpensive to use, and is The present inventors have discovered that this method satisfies patient comfort more than conventional thermotherapy, and have completed the present invention.
すなわち、本発明は、鉄粉、塩類、水および炭素質物質
からなる発熱組成物を収納した化学力イロを熱源として
用いたことを特徴とする表在癌および深部癌治療具に係
る。That is, the present invention relates to a treatment device for superficial cancer and deep cancer, characterized in that a chemical iron containing a heat-generating composition consisting of iron powder, salts, water, and carbonaceous material is used as a heat source.
本発明で用いられる化学力イロには、上記のように鉄粉
、塩類、水および炭素質物質からなる発熱組成物が収納
されるが、これに遠赤外線を発生するセラミック、セオ
ライト、ジルコニウム等から選ばれた1種または2種以
上の物質をさらに加えた化学力イロは、患部のより深部
にまで熱を到達させることができ好ましい。The chemical iron used in the present invention contains a heat-generating composition consisting of iron powder, salts, water and carbonaceous materials as described above. A chemical heat treatment to which one or more selected substances are further added is preferable because it allows heat to reach deeper parts of the affected area.
また、発熱組成物には必要に応じて、木粉、パーライト
などの保水剤、高分子吸水剤あるいはメタケイ酸ナトリ
ウムなどの水素発生抑制剤などを適宜配合することかで
きる。Further, the heat-generating composition may optionally contain a water retaining agent such as wood flour or perlite, a polymeric water absorbing agent, or a hydrogen generation inhibitor such as sodium metasilicate.
発熱組成物を収納するために、空気の通気性が付与され
ている袋が通常使用されるが、この発熱組成物収納袋と
しては例えば紙、不織布に熱融着性合成樹脂をラミネー
トしたフィルムに微孔を形成したものや、微細連続孔を
表面および内部に有するポリエチレン、ポリプロピレン
、ポリウレタン類またはそれらを柔軟に改質したプラス
チック類などからなるフィルムを製袋したものである。In order to store the heat-generating composition, a bag with air permeability is usually used.This heat-generating composition storage bag can be made of, for example, a film made of paper or non-woven fabric laminated with a heat-fusible synthetic resin. Bags are made from films made of polyethylene, polypropylene, polyurethanes, or plastics modified to make them flexible, and which have micropores or continuous micropores on the surface and inside.
また、微細連続孔フィルムは単独で用いても、あるいは
補強のために収納袋として柔軟性を損なわない程度の薄
い不織布などを積層して用いてもよい。これらのフィル
ムから構成される発熱組成物収納袋の形状は任意で、例
えば板状あるいは直腸などに挿入しやすいように管状と
することもできる。また、厚さはその物性、すなわち通
気性、引裂強度、加工性、感触などを考慮して適宜選択
されるが、通常01〜3.0順の範囲で用いられる。Further, the fine continuous pore film may be used alone, or may be used as a storage bag for reinforcement by laminating a thin non-woven fabric or the like to an extent that does not impair flexibility. The shape of the exothermic composition storage bag made of these films is arbitrary, and may be, for example, plate-like or tubular so that it can be easily inserted into the rectum. Further, the thickness is appropriately selected in consideration of its physical properties, that is, air permeability, tear strength, workability, feel, etc., and is usually used in the order of 01 to 3.0.
本発明の癌治療具は、上記化学力イロを熱源として用い
たことに特徴を有し、化学力イロとこれを患部に貼付す
るための貼付材あるいは留置するための保持材などとか
ら構成される装置付材としては、化学力イロの片面もし
くは両面に、粘着剤層を有する両面テープを貼着してお
いてもよいし、別体にて付設したテープを使用時に化学
力イロに貼着するようにしてもよい。The cancer treatment device of the present invention is characterized in that the above-mentioned chemical iron is used as a heat source, and is composed of the chemical iron and a patch for applying it to the affected area or a holding material for indwelling it. As an attachment material for the device, double-sided tape with an adhesive layer may be pasted on one or both sides of the chemical iron, or a separate piece of tape can be attached to the chemical iron during use. You may also do so.
ここで、化学力イロとテープ等の間に適宜生地やソート
等を挟持させて患部温度の調整を図ることもできる。ま
た、直腸なとに管状の化学力イロを挿入する場合、化学
力イロの外側にさらに管状の保持材を配して2層構造と
なし患部に留置しやすい構造とすることもできる。Here, it is also possible to adjust the temperature of the affected area by appropriately sandwiching cloth, sorting material, etc. between the chemical dye and the tape. In addition, when inserting a tubular chemical electrolyte into the rectum, a tubular retaining material may be further placed on the outside of the chemical electrolyte to form a two-layer structure, so that it can be easily placed in the affected area.
なお、本発明の癌治療具は通常密封性フィルムに収納し
て保存し、使用時に開封して使用する。このような本発
明の癌治療具を適用するにあたっては、表在癌の場合に
は患部に、また深部癌の場合には患部に最も熱が伝わり
やすい部位に貼付または留置すればよい。例えば、表在
癌である乳癌に対しては、本発明の癌治療具はブラジャ
ー内部に装着されるのが好適で、腫瘍の温度を43°C
に2〜3時間保ち、火傷の心配もなく手軽に使用するこ
とかできる。また、直腸癌や食道癌のような場合、化学
力イロとその外側に設置された保持材とで2層管状構造
とした本発明の癌治療具を好適に使用することができる
。さらに、大腸癌のような深部癌についても、熱がより
深部まで到達され得る処方の化学力イロを選択して本発
明の癌治療具を適当な部位に適用することが可能である
。The cancer treatment device of the present invention is usually stored in an airtight film and opened when used. When applying the cancer treatment device of the present invention, it may be applied or placed in the affected area in the case of superficial cancer, or at the site where heat is most easily transmitted to the affected area in the case of deep cancer. For example, for breast cancer, which is a superficial cancer, the cancer treatment device of the present invention is preferably worn inside a bra, and the temperature of the tumor is reduced to 43°C.
It lasts for 2 to 3 hours and can be used easily without worrying about getting burned. Further, in cases such as rectal cancer and esophageal cancer, the cancer treatment device of the present invention, which has a two-layered tubular structure consisting of a chemical iron and a retaining material placed on the outside thereof, can be suitably used. Furthermore, even for deep-seated cancers such as colon cancer, it is possible to apply the cancer treatment device of the present invention to an appropriate site by selecting a chemical formula that allows heat to reach deeper areas.
本発明の癌治療具を使用することにより、癌細胞の増殖
を抑えて腫瘍の縮小をもたらし、また、抗題剤や他の化
学療法、放射線療法との併用によって集学的な治療効果
も期待し得るものである。By using the cancer treatment device of the present invention, it is expected that the proliferation of cancer cells will be suppressed and the tumor will shrink, and a multidisciplinary treatment effect will also be achieved when used in combination with anti-inflammatory drugs, other chemotherapy, and radiotherapy. It is possible.
次に本発明の試験例および実施例を示すか、これらは本
発明を説明するためのものであり、制限するものではな
い。Next, test examples and examples of the present invention will be shown, but these are for illustrating the present invention and are not intended to limit it.
試験例1
下記表1の発熱組成物からなる化学力イロ表面に両面テ
ープを貼着して本発明の表在癌および深部癌治療具を作
製し以下の試験に供した。Test Example 1 The superficial cancer and deep cancer treatment devices of the present invention were prepared by attaching a double-sided tape to the chemically heated surface of the exothermic composition shown in Table 1 below, and subjected to the following tests.
表2(表中の経過時間の下に示す数値の単位は°C)ウ
ィスター系ラットに上記本発明の癌治療具を貼着し、貼
着部の表皮温度と大腸温度を測定した。結果と表2に示
す。なお、いずれの化学力イロも日本工業規格の341
00によれば最高温度55〜56°Cを4時間以上持続
するものであった。Table 2 (The unit of the numerical value shown under the elapsed time in the table is °C) The above-mentioned cancer treatment device of the present invention was attached to a Wistar rat, and the epidermal temperature and large intestine temperature of the attached part were measured. The results are shown in Table 2. In addition, all chemical forces comply with 341 of the Japanese Industrial Standards.
According to No. 00, the maximum temperature of 55 to 56°C was maintained for more than 4 hours.
試験の結果、化学力イロ■を用いた場合、表皮温度を4
3℃に保つことかできたが、大腸温度については36°
Cと低かった。一方、遠赤外線発生成分を配合した化学
力イロ■および化学力イロ■を用いた本発明の癌治療具
の場合、大腸温度を42〜43°Cに維持することかで
き、しかも表皮温度と大腸温度との差が小さく、熱がよ
り深部まで到達していることが認められた。As a result of the test, when using Chemical Power Iro■, the epidermal temperature was 4.
I was able to keep it at 3℃, but the colon temperature was 36℃.
It was a low C. On the other hand, in the case of the cancer treatment device of the present invention using Chemical Power Iro■ and Chemical Power Iro■ containing far-infrared generating components, the colon temperature can be maintained at 42 to 43°C, and the epidermal temperature and colon It was observed that the difference in temperature was small, and that the heat reached deeper parts of the body.
なお、化学力イロ■または化学力イロ■と患部との間に
布地等を挟むことによってこれらのカイロを表在癌に適
用することも可能である。In addition, it is also possible to apply these body warmers to superficial cancer by sandwiching a cloth or the like between the chemical force Iro (1) or the chemical force Iro (2) and the affected area.
試験例2
試験例1の化学力イロ■および化学力イロ■を用いてメ
チルコラントレン誘発性皮膚癌に対する効果を検討した
。ウィスター系ラットの背部にメチルコラントレン10
■を3回塗布し、皮膚癌を誘発した。癌の発生を確認し
た後、上記本発明の癌治療具を1日2時間癌発生部位に
貼着し、該治療具の皮膚癌に対する治療効果を調べた。Test Example 2 The effects on methylcholanthrene-induced skin cancer were investigated using Chemical Power Iro (■) and Chemical Power Iro (■) of Test Example 1. Methylcholanthrene 10 on the back of Wistar rats
(2) was applied three times to induce skin cancer. After confirming the occurrence of cancer, the cancer treatment device of the present invention was applied to the cancerous site for two hours a day, and the therapeutic effect of the treatment device on skin cancer was examined.
結果を表3に示す。The results are shown in Table 3.
表3
て癌腫か縮小あるいは消失した。高周波発生装置も効果
はあったか、経済性や簡便性の点で極めて不利で、本発
明の癌治療具の有用性か確認された。Table 3 The carcinoma shrank or disappeared. The high frequency generator was also effective, but it was extremely disadvantageous in terms of economy and simplicity, and the usefulness of the cancer treatment device of the present invention was confirmed.
試験例3
原発性大腸癌を高度に発生する官本ラットを用いて、試
験例】の化学力イロ■および化学力イロ■の癌治療効果
を調へた。結果を表4に示す。Test Example 3 Using Kanmoto rats, which have a high incidence of primary colorectal cancer, the cancer treatment effects of Chemical Power Iro (■) and Chemical Power Iro (2) in Test Example] were investigated. The results are shown in Table 4.
表4
(n=6)
試験の結果、化学力イロ■および化学力イロ■を癌発生
部位に貼着したものは、肉眼的に全試験の結果、化学力
イロ■の大腸癌に対する治療効果は低かったが、化学力
イロ■では担癌率の顕著な低下か見られ治療効果が確認
できた。Table 4 (n=6) As a result of the test, the results of all the tests showed that the therapeutic effect of Chemikyoku Iro■ on colorectal cancer is Although the results were low, a significant decrease in the tumor-bearing rate was observed in Chemiyuki Iro■, confirming the therapeutic effect.
従って、深部癌治療具としては、遠赤外線発生成分を含
有させた化学力イロかより有効であることがわかる。Therefore, it can be seen that the chemical agent containing a far-infrared ray generating component is more effective as a deep cancer treatment device.
実施例1
官本ラット大腸癌の皮下移植癌に対して、試験例1に示
した化学力イロ■を用いる癌治療具を施用したところ、
]力月で皮下腫瘤の著しい縮小が肉眼的に観察された。Example 1 When the cancer treatment device using the chemical force Iro (■) shown in Test Example 1 was applied to subcutaneously transplanted cancer of the colon cancer in government rats,
] Significant shrinkage of the subcutaneous mass was observed macroscopically.
実施例2
試験例1で用いた化学力イロ■をブラジャーの内側に装
着して本発明の表在癌および深部癌治療具を作製し、高
齢者で手術療法を拒否した乳癌患者の腋下部ならびに乳
腺部に適用した。Example 2 A device for treating superficial cancer and deep cancer of the present invention was prepared by attaching the Chekkiyoku Iro ■ used in Test Example 1 to the inside of a bra, and was used to treat the underarm area of an elderly breast cancer patient who refused surgical treatment. Applied to the mammary gland area.
毎日カイロを交換し、1日2時間ずつ低温火傷を起こさ
ないように30日間治療を継続したところ、乳癌の腫瘤
は著しく縮小した。After changing the heating pad every day and continuing the treatment for two hours a day to avoid low-temperature burns for 30 days, the breast cancer mass significantly shrunk.
実施例3
試験例1の化学力イロ■を用いて作製した本発明の表在
癌および深部癌治療具を官本ラットの大腸癌治療のため
に使用し、併せて抗癌剤であるアトレアマイノン、マイ
トマイノンあるいはンスプラチンの腹腔内投与を行った
。1力月間治療を継続したところ、癌腫の縮小か観察さ
れ、また副作用もなく本発明の癌治療具の有用性が確認
された。Example 3 The superficial cancer and deep cancer treatment device of the present invention prepared using the chemical method of Test Example 1 was used for the treatment of colon cancer in Kanmoto rats, and the anticancer agent atreamynon, Mitomynon or nsplatin was administered intraperitoneally. When the treatment was continued for one month, shrinkage of the carcinoma was observed, and there were no side effects, confirming the usefulness of the cancer treatment device of the present invention.
実施例4
直腸癌再発の患者の会陰部に試験例1で用いた化学力イ
ロ■を貼付し、1日6時間の使用で2週間継続したとこ
ろ、腫瘤か縮小し、そしてかんこな痛みか軽減あるいは
消失した。Example 4 When the chemical agent used in Test Example 1 was pasted on the perineum of a patient with rectal cancer recurrence and used for 6 hours a day for 2 weeks, the tumor size decreased and pain was not felt. reduced or disappeared.
本発明の表在癌および深部癌治療具はこれまで詳細に説
明したように、温熱治療の熱源として、鉄粉、塩類、水
および炭素質物質からなる発熱組成物、あるいはこれと
遠赤外線を発生するセラミック、ゼオライト、ンルコニ
ウム等から選ばれた1または2種以上の物質とを収納し
た化学力イロを用いたものである。このような本発明の
癌治療具は、癌患者の健全な部位に障害を与えることな
く癌組織のみを死滅させることができ、かつ患者の快適
性を満足させ、しかもいつでも、とこでも安価で手軽に
使用できるものである。As explained in detail so far, the superficial cancer and deep cancer treatment device of the present invention uses a heat generating composition consisting of iron powder, salts, water and carbonaceous material, or a heat generating composition consisting of iron powder, salts, water and carbonaceous material, or generates far infrared rays together with this as a heat source for thermotherapy. It uses a chemical ceramic containing one or more substances selected from ceramic, zeolite, luconium, etc. The cancer treatment device of the present invention is capable of killing only cancerous tissue without causing damage to healthy areas of cancer patients, satisfies patient comfort, and can be used anytime, anywhere at low cost and easily. It can be used for
特許出願人大日本除虫菊株式会社Patent applicant Dainippon Pyrethrum Co., Ltd.
Claims (2)
成物を収納した化学力イロを熱源として用いたことを特
徴とする表在癌および深部癌治療具。(1) A treatment device for superficial cancer and deep cancer, characterized in that a chemical iron containing a heat generating composition consisting of iron powder, salts, water and carbonaceous material is used as a heat source.
成物および遠赤外線を発生するセラミック、ゼオライト
、ジルコニウム等から選ばれた1種または2種以上の物
質を収納した化学カイロを熱源として用いたことを特徴
とする表在癌および深部癌治療具。(2) As a heat source, a chemical body warmer containing one or more substances selected from heat-generating compositions consisting of iron powder, salts, water, and carbonaceous substances, and ceramics that generate far infrared rays, zeolites, zirconium, etc. A treatment device for superficial cancer and deep cancer, characterized in that it is used for the treatment of superficial cancer and deep cancer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2204101A JP2873730B2 (en) | 1990-08-01 | 1990-08-01 | Superficial and deep cancer treatment devices |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2204101A JP2873730B2 (en) | 1990-08-01 | 1990-08-01 | Superficial and deep cancer treatment devices |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0489051A true JPH0489051A (en) | 1992-03-23 |
JP2873730B2 JP2873730B2 (en) | 1999-03-24 |
Family
ID=16484817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2204101A Expired - Fee Related JP2873730B2 (en) | 1990-08-01 | 1990-08-01 | Superficial and deep cancer treatment devices |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2873730B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012021018A (en) * | 2005-04-29 | 2012-02-02 | Tomizo Yamamoto | Activated foam |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101024468B1 (en) * | 2010-08-20 | 2011-03-23 | 정일우 | Operating system for exposing tumor mass |
-
1990
- 1990-08-01 JP JP2204101A patent/JP2873730B2/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012021018A (en) * | 2005-04-29 | 2012-02-02 | Tomizo Yamamoto | Activated foam |
US9125819B2 (en) | 2005-04-29 | 2015-09-08 | Tomizo Yamamoto | Activated foam |
Also Published As
Publication number | Publication date |
---|---|
JP2873730B2 (en) | 1999-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Short et al. | Physical hyperthermia and cancer therapy | |
Connor et al. | Prospects for hyperthermia in human cancer therapy: Part II: Implications of biological and physical data for applications of hyperthermia to man | |
RU2508136C2 (en) | Portable radio-frequency hyperthermic device with flexible therapeutic electrode for capacitive electric energy transfer | |
US8016868B2 (en) | Reflective heat patch | |
JP2011510698A (en) | Flexible and porous large area heating electrode | |
WO1997049361A1 (en) | Thermal pad having a common attachment and oxygen permeable side | |
CN106726165A (en) | A kind of disposable adsorption object | |
JP2826667B2 (en) | Sweat-absorbing thermal structure | |
Perez et al. | Local microwave hyperthermi and irradiation in cancer therapy: Preliminary observations and directions for future clinical trials | |
WO2006006663A1 (en) | Moxibustion device | |
CN104873323A (en) | Medical magnetic therapy type hot compressing patch for treating soft tissue pain and preparation method thereof | |
JPH0489051A (en) | Superficial cancer and deep cancer therapeutic tool | |
CN202044401U (en) | Hot compress sticker | |
CN208799397U (en) | A kind of hot compress care device that rheumatism is immune | |
JP2873737B2 (en) | Superficial and deep cancer treatment devices | |
CN209475140U (en) | A kind of reusable moxibustion plaster | |
CN104826234A (en) | Self-heating medical magnetic therapy infrared tepid paste and preparation method thereof | |
KR100334490B1 (en) | an infrared mat | |
CN211356105U (en) | Waist protecting belt with waist supporting function | |
CN211214954U (en) | Wearable hot compress adhesive film | |
WO2011065184A1 (en) | Analgesic agent for external use, analgesic sheet, fabric, clothes, wall material, thermotherapeutic instrument, brain activation sheet and small pillow for brain activation | |
JPH02174861A (en) | Hyperthermia sheet | |
TWM529517U (en) | Heating dressing material structure | |
CN209790603U (en) | Foot pad | |
KR20020079119A (en) | functional local heating divice with surface heating pad |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080114 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090114 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090114 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100114 Year of fee payment: 11 |
|
LAPS | Cancellation because of no payment of annual fees |